These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36553250)
1. CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male. Rodak M; Jonderko M; Rozwadowska P; Machnikowska-Sokołowska M; Paprocka J Children (Basel); 2022 Nov; 9(12):. PubMed ID: 36553250 [TBL] [Abstract][Full Text] [Related]
2. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder. Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384 [TBL] [Abstract][Full Text] [Related]
3. CDKL5 deficiency disorder in males: Five new variants and review of the literature. Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939 [TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants. Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160 [TBL] [Abstract][Full Text] [Related]
11. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients. Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227 [TBL] [Abstract][Full Text] [Related]
12. Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder. Leonard H; Junaid M; Wong K; Demarest S; Downs J Epilepsy Res; 2021 Jan; 169():106521. PubMed ID: 33341033 [TBL] [Abstract][Full Text] [Related]
16. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients. Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of early myoclonic encephalopathy caused by a CDKL5 mutation. Takeda K; Miyamoto Y; Yamamoto H; Ishii A; Hirose S; Yamamoto H Brain Dev; 2020 Jan; 42(1):73-76. PubMed ID: 31492455 [TBL] [Abstract][Full Text] [Related]
19. A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder. Tangarorang J; Leonard H; Epstein A; Downs J Am J Med Genet A; 2019 Feb; 179(2):249-256. PubMed ID: 30561084 [TBL] [Abstract][Full Text] [Related]
20. Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand). Saldaris J; Leonard H; Jacoby P; Marsh ED; Benke TA; Demarest S; Downs J J Child Neurol; 2022 May; 37(6):541-547. PubMed ID: 35422141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]